To access the full text documents, please follow this link: http://hdl.handle.net/2445/98471

Title:	Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain
Author:	Campa, Adela G. de la; Ardanuy Tisaire, María Carmen; Balsalobre, Luz; Pérez Trallero, Emilio; Marimón, José María; Fenoll, Asunción; Liñares Louzao, Josefina
Other authors:	Universitat de Barcelona
Abstract:	Among 4,215 Streptococcus pneumoniae isolates obtained in Spain during 2006, 98 (2.3%) were ciprofloxacin resistant (3.6% from adults and 0.14% from children). In comparison with findings from a 2002 study, global resistance remained stable. Low-level resistance (30 isolates with MIC 4-8 μg/mL) was caused by a reserpine-sensitive efflux phenotype (n = 4) or single topoisomerase IV (parC [n = 24] or parE [n = 1]) changes. One isolate did not show reserpine-sensitive efflux or mutations. High-level resistance (68 isolates with MIC ≥16 μg/mL) was caused by changes in gyrase (gyrA) and parC or parE. New changes in parC (S80P) and gyrA (S81V, E85G) were shown to be involved in resistance by genetic transformation. Although 49 genotypes were observed, clones Spain9V-ST156 and Sweden15A-ST63 accounted for 34.7% of drug-resistant isolates. In comparison with findings from the 2002 study, clones Spain14-ST17, Spain23F-ST81, and ST8819F decreased and 4 new genotypes (ST9710A, ST57016, ST43322, and ST71733) appeared in 2006.
Subject(s):	-Estreptococs -Pneumococs -Infeccions per pneumococs -Vacuna antipneumocòccica -Resistència als medicaments -Espanya -Streptococcus -Streptococcus pneumonia -Pneumococcal Infections -Pneumococcal vaccine -Drug resistance -Spain
Rights:	Domini públic / Public domain http://creativecommons.org/publicdomain/zero/1.0/
Document type:	Article Article - Published version
Published by:	Centers for Disease Control and Prevention
Share:

Show full item record